Molecular mechanisms of cancer development in obesity

[1]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[2]  M. Stampfer,et al.  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. , 1998, Science.

[3]  A. Ootani,et al.  Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[4]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[5]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[6]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[7]  D. Berrigan,et al.  Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. , 2006, Cancer research.

[8]  G. Davey Smith,et al.  Childhood body mass index and later cancer risk: A 50‐year follow‐up of the Boyd Orr study , 2004, International journal of cancer.

[9]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[10]  D. Pravtcheva,et al.  Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice. , 1998, The Journal of experimental zoology.

[11]  M. Herridge.  NFKBIA Deletion in Glioblastomas , 2011 .

[12]  H. Ellingsgaard,et al.  Increased Number of Islet-Associated Macrophages in Type 2 Diabetes , 2007, Diabetes.

[13]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[14]  Dallas R. English,et al.  Body size and composition and prostate cancer risk: systematic review and meta-regression analysis , 2006, Cancer Causes & Control.

[15]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[16]  C. Rock,et al.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  N. Fausto,et al.  Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice , 2000, The Journal of experimental medicine.

[18]  G. Baretton,et al.  Overexpression of the insulin‐like growth factor I receptor in human colon carcinomas , 2002, Cancer.

[19]  E. Siegel,et al.  Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Frystyk,et al.  Circulating levels of free insulin‐like growth factors in obese subjects: the impact of Type 2 diabetes , 1999, Diabetes/metabolism research and reviews.

[21]  Increased population prevalence of reflux and obesity in the United Kingdom compared with Sweden: a potential explanation for the difference in incidence of esophageal adenocarcinoma , 2011, European journal of gastroenterology & hepatology.

[22]  H. Grosse.  [Diabetes and cancer]. , 1956, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten.

[23]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[24]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[25]  C. Mantzoros,et al.  Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. , 2008, JAMA.

[26]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[27]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[28]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[29]  J. Baron,et al.  Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States) , 2006, Cancer Causes & Control.

[30]  S. Lenzen,et al.  Peroxisome-Generated Hydrogen Peroxide as Important Mediator of Lipotoxicity in Insulin-Producing Cells , 2010, Diabetes.

[31]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[32]  L. Appel,et al.  Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. , 2011, The American journal of clinical nutrition.

[33]  H. Yatsuya,et al.  Leptin Is Associated with an Increased Female Colorectal Cancer Risk: A Nested Case-Control Study in Japan , 2005, Oncology.

[34]  J. Frystyk,et al.  Bioactive insulin-like growth factor-I in obesity. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  J. Reynolds,et al.  Leptin and gastro‐intestinal malignancies , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[36]  J. Peters,et al.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.

[37]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[38]  P. Stattin,et al.  Leptin is associated with increased prostate cancer risk: a nested case-referent study. , 2001, The Journal of clinical endocrinology and metabolism.

[39]  R. Moon,et al.  Adiponectin Haploinsufficiency Promotes Mammary Tumor Development in MMTV-PyVT Mice by Modulation of Phosphatase and Tensin Homolog Activities , 2009, PloS one.

[40]  C. Friedenreich,et al.  Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[41]  J. Rüschoff,et al.  Enhancement of experimental metastasis by tumor necrosis factor , 1993, The Journal of experimental medicine.

[42]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[43]  G. Kollias,et al.  Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. , 1999, Nature medicine.

[44]  L. Shaw,et al.  Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis , 2004, Molecular and Cellular Biology.

[45]  L. Jacobs,et al.  Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[47]  T. Sugimura,et al.  Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. , 2008, Carcinogenesis.

[48]  C. Osborne,et al.  Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[50]  J. Foekens,et al.  Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  F. Anania,et al.  Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis , 2010, Hepatology.

[52]  J. Kral,et al.  Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. , 2004, Gastroenterology.

[53]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[54]  J. Jorcano,et al.  Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Viollet,et al.  Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. , 2010, Cell metabolism.

[56]  R. Zechner,et al.  Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. , 2010, The Journal of clinical investigation.

[57]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[58]  C. Mantzoros,et al.  Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. , 2007, The American journal of clinical nutrition.

[59]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[60]  L. Esserman,et al.  Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome , 2011, Breast Cancer Research and Treatment.

[61]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[62]  J. Manson,et al.  Prospective Study of , 2007 .

[63]  E. Calle,et al.  Cancer Incidence and Mortality After Gastric Bypass Surgery , 2009, Obesity.

[64]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[65]  Antony Hsieh,et al.  IGFBP2 promotes glioma tumor stem cell expansion and survival. , 2010, Biochemical and biophysical research communications.

[66]  A. Sood.  Pulmonary Physiology and Pathophysiology in Obesity Obesity , adipokines , and lung disease , 2010 .

[67]  N. Mukaida,et al.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. , 2008, The Journal of clinical investigation.

[68]  J. Manson,et al.  Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[69]  D. Leroith,et al.  Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression , 2009, Diabetes.

[70]  C. Mantzoros,et al.  Circulating adiponectin and endometrial cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[71]  M. Kolonin,et al.  Adipose tissue-derived progenitor cells and cancer. , 2010, World journal of stem cells.

[72]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Birnbaum,et al.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.

[74]  U. Broedl,et al.  Adipokines and Insulin Resistance , 2008, Molecular medicine.

[75]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[76]  Alexander S. Banks,et al.  Activation of Downstream Signals by the Long Form of the Leptin Receptor* , 2000, The Journal of Biological Chemistry.

[77]  E. Jaffee,et al.  Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice , 2005, Oncogene.

[78]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[79]  J. Foidart,et al.  Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. , 2008, Cancer cell.

[80]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[81]  J. Lagergren,et al.  Risk of Obesity-Related Cancer After Obesity Surgery in a Population-Based Cohort Study , 2010, Annals of surgery.

[82]  Rajnish A. Gupta,et al.  Activation of nuclear hormone receptor peroxisome proliferator–activated receptor-δ accelerates intestinal adenoma growth , 2004, Nature Medicine.

[83]  E. Gale,et al.  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes , 2009, Diabetologia.

[84]  F. Caldefie‐Chézet,et al.  Molecular mechanisms of leptin and adiponectin in breast cancer. , 2011, European journal of cancer.

[85]  D. Bol,et al.  Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice , 1997, Oncogene.

[86]  D. Loskutoff,et al.  Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. , 1991, The Journal of clinical investigation.

[87]  B. Spiegelman,et al.  Synergy between PPARgamma ligands and platinum-based drugs in cancer. , 2007, Cancer cell.

[88]  D. Hardie,et al.  Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. , 2010, Biochimica et biophysica acta.

[89]  T. Luedde,et al.  Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis , 2008, Proceedings of the National Academy of Sciences.

[90]  M. Lichtman.  Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma , 2010, The oncologist.

[91]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[92]  L. Lund,et al.  Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.

[93]  M. Dieudonné,et al.  Leptin mediates a proliferative response in human MCF7 breast cancer cells. , 2002, Biochemical and biophysical research communications.

[94]  R. Hammer,et al.  White Fat Progenitor Cells Reside in the Adipose Vasculature , 2008, Science.

[95]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[96]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[97]  R. Robertson,et al.  β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .

[98]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[99]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[100]  P. Meier,et al.  Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. , 1991, The American journal of physiology.

[101]  M. Stampfer,et al.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.

[102]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[103]  D. Berrigan,et al.  Obesity Accelerates Mouse Mammary Tumor Growth in the Absence of Ovarian Hormones , 2008, Nutrition and cancer.

[104]  M. Loda,et al.  Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[106]  M. Stampfer,et al.  A prospective study of plasma C-peptide and colorectal cancer risk in men. , 2004, Journal of the National Cancer Institute.

[107]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[108]  J. Ajani,et al.  A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer , 2005, Clinical & Experimental Metastasis.

[109]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[110]  H. Colhoun,et al.  Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group , 2009, Diabetologia.

[111]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[112]  J. Friedman,et al.  Selective deletion of leptin receptor in neurons leads to obesity. , 2001, The Journal of clinical investigation.

[113]  J. Bub,et al.  Prostate Cancer Cell-Adipocyte Interaction , 2003, Journal of Biological Chemistry.

[114]  B. Spiegelman,et al.  Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer , 2007 .

[115]  W. Willett,et al.  Plasma adiponectin concentrations and risk of incident breast cancer. , 2006, The Journal of clinical endocrinology and metabolism.

[116]  C. Giordano,et al.  Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor α in MCF-7 Cells* , 2004, Journal of Biological Chemistry.

[117]  T. Willson,et al.  Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines , 2007 .

[118]  L. Chodosh,et al.  Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation , 2007, Oncogene.

[119]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[120]  N. Ferrara.  Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action , 2010, Molecular biology of the cell.

[121]  A. Greenberg,et al.  Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. , 1998, The Journal of clinical endocrinology and metabolism.

[122]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[123]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[124]  R. Bird,et al.  Elevated expression of tumor necrosis factor‐α signaling molecules in colonic tumors of Zucker obese (fa/fa) rats , 2010, International journal of cancer.

[125]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[126]  David M. Sabatini,et al.  Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.

[127]  P. Björntorp,et al.  A morphological study of the adipocyte precursor. , 1984, Journal of submicroscopic cytology.

[128]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[129]  H. Lodish,et al.  Adiponectin Deficiency Promotes Tumor Growth in Mice by Reducing Macrophage Infiltration , 2010, PloS one.

[130]  L. Riste,et al.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations , 2001, Diabetologia.

[131]  C. Giordano,et al.  Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. , 2004, The Journal of biological chemistry.

[132]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[133]  M. Narasimhan,et al.  Role of the adiponectin leptin ratio in prostate cancer. , 2009, Oncology research.

[134]  P. Leung,et al.  Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. , 2005, The Journal of clinical endocrinology and metabolism.

[135]  E. Simpson,et al.  Obesity and breast cancer: progress to understanding the relationship. , 2010, Cancer research.

[136]  R. Broaddus,et al.  Overexpression of the Insulin-Like Growth Factor I Receptor and Activation of the AKT Pathway in Hyperplastic Endometrium , 2006, Clinical Cancer Research.

[137]  J. Reddy,et al.  Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.

[138]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[139]  S. Deventer,et al.  Leptin is a growth factor for colonic epithelial cells. , 2001, Gastroenterology.

[140]  T. Sugimura,et al.  High susceptibility to azoxymethane‐induced colorectal carcinogenesis in obese KK‐Ay mice , 2011, International journal of cancer.

[141]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[142]  G. Steineck,et al.  Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden , 2009, Diabetologia.

[143]  JoAnn E Manson,et al.  Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. , 2003, Diabetes care.

[144]  John Turk,et al.  Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.

[145]  Jeffrey W. Smith,et al.  Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.

[146]  J. Bub,et al.  Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.

[147]  D. Leroith,et al.  Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. , 2010, Cancer research.

[148]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[149]  Sung-Ae Jung,et al.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. , 2010, Molecular Endocrinology.

[150]  Lotfi Chouchane,et al.  Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma , 2006, BMC Cancer.

[151]  Jessica M. Silvaggi,et al.  Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin , 2008, Clinical Cancer Research.

[152]  C. Mantzoros,et al.  Leptin in relation to carcinoma In situ of the breast: A study of pre‐menopausal cases and controls , 1999, International journal of cancer.

[153]  Adrian V. Lee,et al.  Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. , 2005, Cancer research.

[154]  Suzanne Schubbert,et al.  Hyperactive Ras in developmental disorders and cancer , 2007, Nature Reviews Cancer.

[155]  R. Brand,et al.  Elevated insulin receptor content in human breast cancer. , 1990, The Journal of clinical investigation.

[156]  M. Skobe,et al.  Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.

[157]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[158]  Edi Brogi,et al.  Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer , 2011, Cancer Prevention Research.

[159]  B. Spiegelman,et al.  Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.

[160]  S. Majumdar,et al.  Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin , 2006, Diabetes Care.

[161]  C. Mantzoros,et al.  Leptin in relation to prostate cancer and benign prostatic hyperplasia. , 1998, International Journal of Cancer.

[162]  S. Hankinson,et al.  Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. , 2011, American journal of obstetrics and gynecology.

[163]  Kathleen R. Cho,et al.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. , 2011, The Journal of clinical investigation.

[164]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[165]  S. Yakar,et al.  Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. , 2010, Cancer research.

[166]  A. Wolff,et al.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. , 2008, JAMA.

[167]  J. Kutok,et al.  Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. , 2010, Cancer cell.

[168]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[169]  H. Lodish,et al.  Standard Isolation of Primary Adipose Cells from Mouse Epididymal Fat Pads Induces Inflammatory Mediators and Down-regulates Adipocyte Genes* , 2003, Journal of Biological Chemistry.

[170]  W. Arap,et al.  White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. , 2009, Cancer research.

[171]  R. Khokha,et al.  Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma , 2003, Oncogene.

[172]  J. Meyerhardt,et al.  Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[173]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[174]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[175]  J. Abbruzzese,et al.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[176]  C. Peterson,et al.  Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. , 2009, American journal of physiology. Endocrinology and metabolism.

[177]  S. Chua,et al.  Tumorigenesis and Neoplastic Progression Leptin Receptor Signaling Supports Cancer Cell Metabolism through Suppression of Mitochondrial Respiration in Vivo , 2010 .

[178]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[179]  P. Smaglik,et al.  New perspectives , 2011, Nature.

[180]  Tran Van Nhieu G.  Pathogenic paradox? , 1999, Trends in microbiology.

[181]  D. Hanahan,et al.  Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. , 2002, Cancer cell.

[182]  R. Robertson,et al.  Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. , 2004, Diabetes.

[183]  Jeffrey S. Morris,et al.  Body Mass Index and Risk , Age of Onset , and Survival in Patients With Pancreatic Cancer , 2009 .